nanoparticle RNA vaccine
Jump to navigation
Jump to search
Principle
- nanoparticles containing RNA that encoding specific pathogen proteins
- an RNA replicon contains a start signal, coding region a protein & a stop signal
- once inside a cell, the replican can produce protein
- vaccine against a specific microbe can be created in 1 week
Comparative biology
- mice provided a single dose nanoparticle RNA vaccine for H1N1 influenza, Toxoplasma gondii, or Ebolavirus sustained protection against lethal doses of each of these pathogens
- no evidence of an immune response against the nanoparticle
More general terms
References
- ↑ Chahal JS, Khan OF, Cooper CL et al. Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose. Proc Natl Acad Sci U S A 2016 Jul 19; 113:E4133. PMID: https://www.ncbi.nlm.nih.gov/pubmed/27382155